Language selection

Search

Patent 1246066 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1246066
(21) Application Number: 464861
(54) English Title: METHOD FOR THE PREPARATION OF A PHARMACEUTICALLY USABLE BENZOTHIAZINE DIOXIDE, AND AN INTERMEDIATE FOR USE IN THE METHOD
(54) French Title: METHODE DE PREPARATION D'UN DIOXYDE DE BENZOTHIAZINE UTILISABLE EN PHARMACIE ET INTERMEDIAIRE POUVANT ETRE UTILISE AVEC CETTE METHODE
Status: Expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 260/243.21
(51) International Patent Classification (IPC):
  • C07D 279/02 (2006.01)
  • C07D 417/12 (2006.01)
(72) Inventors :
  • KAIRISALO, PEKKA (Finland)
  • HONKANEN, ERKKI (Finland)
  • JOHANSSON, MAGNUS (Finland)
  • KURIMO, RITVA (Finland)
  • NORE, PENTTI (Finland)
  • PIPPURI, AINO (Finland)
  • KARHU, MATTI (Finland)
(73) Owners :
  • PFIZER LIMITED (United States of America)
(71) Applicants :
(74) Agent: SMART & BIGGAR
(74) Associate agent:
(45) Issued: 1988-12-06
(22) Filed Date: 1984-10-05
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
833628 Finland 1983-10-06

Abstracts

English Abstract



ABSTRACT

This invention relates to a method for the preparation of a
pharmaceutically usable 2-methyl-4-hydroxy-2H-1,2-benzothiazine-
1,1-dioxide with formula I


Image
I


In accordance with the invention 2-methyl-4-mesyloxy-2H,1,2-
benzothiazine-1,1-dioxide-3-carboxylic acid with formula II


Image
II

is reacted with 2-aminopyridine in the presence of thionyl
chloride in an inert solvent. The invention relates also to
the intermediate with formula II which can be used in the method.


Claims

Note: Claims are shown in the official language in which they were submitted.



- 8 -

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:

1. A method for the preparation of pharmaceutically
useful 2-methyl-4-hydroxy-2H-1,2-benzothiazine-1,1-dioxide-
3-(N-2-pyridyl)carboxamide of the formula:



Image (I)


which comprises reacting 2-methyl-4-mesyloxy-2H-1,2-

benzothiazine-1,1-dioxide-3-carboxylic acid of the formula:


Image
(II)

or its dimethylacetamide solvate, with 2-aminopyridine in the
presence of thionyl chloride in an inert solvent.


2. A method according to claim 1, wherein the reaction
is carried out at a temperature of 40 to 85°C, and after the
amidation, the reaction product is treated with a dilute
aqueous NaOH solution to remove the mesyl group.


3. A method according to claim 2, wherein also a tertiary
amine is used in the reaction.

4. A method according to claim 3, wherein the tertiary
amine is 2,6-dimethylpyridine.



- 9 -

5. A process according to claim 1, wherein the
carboxylic acid (II) or its dimethylacetamide solvate is
reacted with an approximately equimolar amount of 2-
aminopyridine.

6. A process according to claim 1, 2 or 3, wherein the
carboxylic acid (II) or its dimethylacetamide solvate is
reacted with an approximately equimolar amount of 2-
aminopyridine in the presence of an excessive molar amount
(per mole of the carboxylic acid (II)) of thionyl chloride.

7. A process according to claim 1, 2 or 3, wherein the
carboxylic acid (II) is prepared by hydrogenating benzyl 2-
methyl-4-mesyloxy-2H-1,2-benzothiazine-1,1-dioxide-3-
carboxylate in the presence of a hydrogenation catalyst.

3. A process according to claim 2 or 3, wherein the
carboxylic acid (II) or its dimethylacetamide solvate is
reacted with an approximately equimolar amount of 2-
aminopyridine.


9. A process for producing 2-methyl-4-hydroxy-2H-1,2-
benzothiazine-1,1-dioxide-3-(N-2-pyridyl)carboxylate which
comprises:
hydrogenating benzyl 2-methyl-4-mesyloxy-1,2-benzo-
thiazine-1,1-dioxide-3-carboxylate in the presence of a
hydrogenation catalyst in N,N-dimethylacetamide solvent to
produce 2-methyl-4-mesyloxy-2H-1,2-benzothiazine-1,1-dioxide-
3-carboxylic acid N,N-dimethylacetamide solvate, and
reacting the carboxylic acid solvate produced in
the preceeding step with an approximately equimolar amount
of 2-aminopyridine at a temperature of 40 to 85°C in the



- 10 -
presence of an excessive molar amount of thionyl chloride
in a reaction inert solvent, followed by the treatment of
the amidation product with a dilute aqueous NaOH solution
to remove the mesyl group.


10. A process of claim 9, wherein the amidation reaction
is carried out in 1,2-dichloroethane solvent at a reflux
temperature of the solvent.


11. An intermediate 2-methyl-4-mesyloxy-2H-1,2-
benzothiazine-1,1-dioxide-3-carboxylic acid of the formula



Image
(II)


or its solvate with N,N-dimethylacetamide.


12. A process for producing the carboxylic acid of
formula (II) as defined in claim 11, which comprises
hydrogenating benzyl 2-methyl-4-mesyloxy-1,2-benzothiazine-
1,1-dioxide-3-carboxylate in the presence of a hydrogenation
catalyst in an inert solvent.

13. A process according to claim 12, wherein N,N-
dimethylacetamide is used as the solvent and N,N-
dimethylacetamide solvate of the carboxylic acid (II) is
produced.


Description

Note: Descriptions are shown in the official language in which they were submitted.



-1- 72222-77


A method for the preparation oE a pharmac0utically usable
benzothiazine dioxide, and an intermediate for use in the
method



The present invention relates to a method for the preparation
of a pharmaceutically useful 2-methyl-4-hydroxy-2H-1,2-
benzothiazine-l,l-dioxide-3-(N-2-pyridyl)-carboxamide, i.e.

piroxicam, having the formula
OH

~-CH 3

and to a new intermediate, 2-methyl~4-mesyloxy-2H-1,2-
benzothiazine-l,l~dioxide-3-carboxylic acid, for carrying
out the said reaction. The formula of the intermediate is

CH3-S02-0
COOH
J S,N-CH3 II



Piroxicam has proved to be a highly usable anti-inflammatory
and analgesic agent which does not have the harmful effects
steroids usually have. Methods for the preparation of
piroxicam have been presented in numerous Finnish and foreign
patent specifications, of which can be mentioned Finnish
Patents 51189, 59592, 62297 and 63573.




The best method with respect of yield is presented in Finnish
Patent 51189. In the method of Patent 51189, the 3-carboxylic
acid ester of 3,4-dihydro-4-oxo-2H-1,2-benzothia~ine-carboxamide-
l,l-dioxide is allowed to react with an at least equimolar amount
of an amine which contains the desired aromatic part, which in
the case of piroxicam is pyridyl. The yield obtained using the




'; J

~2~ 6~;
-2- 72222-77


~ethod in question is about 70%.



A somewhat better yield is obtained by a similar to but different
from the method according to Finnish Pate~ 51189 only with
respect to the esterized group. Thus, in Pate~t 51189, methyl
ester is used as the ester of the carboxylic acid in the 3-
position, and in the other method methoxyethyl ester is used
instead.



The above-mentioned methods based on an aminolysis reaction of
the respective ester of 1,2 benzothiazine-3-carboxylic acid
ln and 2-aminopyridine are, it is true, suitable for industrial
production owing to their yield and also to their other properties,
but their disadvantages include the use of a high temperature,
involving temperatures of boiling xylene, and a very long reaction
time, which is usually more than 20 hours. Both the temperature
and the long reaction time tend to have a decomposing effect on
the product, in which case -the purification of the product is
difficult and the yield tends to decrease owing to
decomposition. Purification is further complicated especially

because the methods in question produce colored byproducts which

require numerous leachings and recrystallizations, and also other
steps, in order to yield an acceptable final product.




Another method for the preparation of piroxicam that is worth
mentioning is presented in Finnish Patent 63573. In the said
specification the starting material is a compound having
the formula

~ CONHR2
~ S,~-CH3
b2

~2~



wherein Z is isopropoxy and R2 is 2-pyridyl when the product
desired is piroxicam, The compound is contacted with an
inor~anic acid, whereby ~he isopropoxy group is caused to
break off. The total yleld ob~alned by thls method 1~ very
poor, for before the breaking off of the isopropoxy group
the preparation also includes ~he llnking of an aminopyridyl
group to the benzothiazine, which is preceded by the conversion
of the 3-acetyl compound to the respective 3 carboxylic acid
Thus the total yield o~tained is only about 2 ~. The dis-
advantages of the said method are not limited to the poor
yield, for the method includes several steps using detrimental
solvents such as benzene and strong acid such as 32 %
hydrobromic acid, by means of which the isopropyl group is
broken off. The method is not suitable for industrial
production.

The object of the present invention is to provide a method
by which piroxicam can be produced with a very good yield
and by using reaction steps which are both easy to carry
out and rapid to complete. It is also an object to obtain
as pure a final product as possible.

The method of the invention for the preparation of piroxicam,
2~methyl-4-hydroxy-2H-1,2-benzcthiazine-l,l~dioxide-3 (N-2-
pyridyl) carboxamide,
OH

~-HN~3 I
b2




is characterized in that 2-methyl-4-mesyloxy-2H-l,l-
benzothiazine-l,l-dioxide-3-carboxylic acid or its solvate
with dimethyl acetamide

- 4 - 4680-325
CH3~SO2-O /CH3 ~
,C0~N (C 3 \ ) II




(n is O or 1)
is reacted with 2-aminopyridine of the formula


H2N - ~ III


in ~he presence o~ thionyl chloride in an inert solvent.

The starting material II and 2-aminopyridine are used in
approximately equimolar amounts, whereas thionyl chloride
can be used in excess, for example about a double amount.
Inert solvents suitable for use include chlorinated hydro-

carbons such as dichloromethane (boiling point about 40C), or1,2-dichlorethane (boiling point 83-84C), acetonitrile
~boiling point about 82C), etc. The reaction is conveniently
carxied out at a temperature of about 40 to 85C, particularly
by reflux at a boiling point of the solvent. The reaction
usually reaches completion within 2-3 hours. When desired, it
is also possible to use in the reaction a tertiary amine such
as 2,6-dimethyl pyridine, a]though it has very little effect
on the reaction.

When the method of the invention is used for the preparation

of piroxicam, the entire reaction takes place under quite
mild conditions. Thus the reaction with 2-aminopyridine occurs
at a moderate temperature and rapidly. Likewise, the mesyl
group can be removed under very mild conditions, for the
breaking off takes place immediately after the acylation
reaction, by using a dilute NaOH solution.



- 5 - 4680-325
Owing to the low temperature, the short reaction time, and
the mild conditions the piroxicam obtained as the final
product is very pure, whereupon several of the steps used for
purification in known methods can be eliminated. Likewise, owing
to the factors mentioned above, the yield is high, on average
86~. The method of the invention further includes one
surprising feature, namely that an acid acceptor is not
necessarily needed in the method at all. Evidently the N,N-
dimethyl acetamide used, which forms a solvate with the
starting material, being an aprotic solvent, effectively
catalyses the acylation reaction of 2-aminopyridine, whereupon
the acid acceptor becomes unnecessary.

The invention also relates to an intermediate of the formula

CH3-S02-0
COOH II

N-CH


2
which is a new compound. Especially for the method according
to the present invention it is advantageous that the said
intermediate forms a solvate with dimethyl acetamide.

The preparation of the intermediate~starting material) is best
carried out by hydrogenating benzyl 2-methyl-4-mesyloxy-

2H-1,2-benzothiazine-1,1-dioxide-3-carboxylate o~ the formula




C ~ COOCH2 ~ IV



2
in the presence of a hydrogenation catalyst in an inert solvent
~or example N,N-dimethylacetamide. The starting material

i~

~6f~6~i

- 5a - 4680-325

benzyl-2-methyl-4-mesyloxy-1,2-benzothiazine-1,1-dioxide-3-
carboxylate, for its part can be prepared, with an almost




~"

i6



theoretical yield, by m~sylat$on by conventlonal ~rocedures
from the respectlve 4-hydroxy compound.

Benzyl-2~methyl-4~hydroxy-1,2-benzothiaz~ne~ dloxlde-3-
carboxylate is a known compound which has been presented ln,
for example,EP Patent Application 82303978.9, publication
number 77 603.

The following examples illustrate the invention without
confining it in any way.

Example 1

2-methyl-3-carboxy-4-mesyloxy-2H-1/2-benzothiazine~
dioxide-N,N-dimethylacetamide solvate

A solution which contained 42.3 g (0.1 mole) of benzyl-2-
methyl-4-mesyloxy-2H-1,2-benzothiazine-1,1-dioxide-3-
carboxylate ~m.p. 110-112 C), 8.7 g (0.1 mole) of N,N-
dimethyl acetamiae, and 2 g of 10 % palladium charcoal
catalyst was hydrogenated for 3 hours at normal pressure and
room temperature. The catalyst was filtered off and the
solvent was distilled off at a lowered pressure, whereby
41.8 ~ (99.5 % of the theoretical amount) of the desired
product ~m.p. 102-104 C) was obtained.

Example 2

2-methyl-4-hydroxy-2H-1,2-benzothiazine-1l1-dioxide-3-(N-2-
pyridyl)-carboxamide (piroxicam3

To a solution which contained 16.8 g (0.040 mole) of the
intermediate prepared in Example 1 and 4.0 g ~0.043 mole)
of 2-aminopyridine in 200 ml of boiling 1,2-dichlorethane,
and possibly 4.3 g (0.40 mole) of 2,6-dimethylpyridine, was




added 9.5 9 (0.08 mole) thionyl chloride whlle stirring,
ln the course of 0.5 hours. The mixture was refluxed for
2 hours, whereafter the mixture was cooled to about 40 C,
and about 500 ml of 0,5 N NaOH solution was added to it
gradually while stirring. The stirring was continued for
another 0.5 hour at a temperature of 40 C. ~hereafter the
aqueous layer was separated, and it was washed with methylPne
chloride, filtered and made mildly acidic by means of acetic
acid, whereupon the desired product crystallized. The product
was filtered and dried, whereby 11.4 g (86 % of the
theoretical amount) of the desired product, m.p. 198-200 C
(purity > 98 %), was obtained.

Representative Drawing

Sorry, the representative drawing for patent document number 1246066 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1988-12-06
(22) Filed 1984-10-05
(45) Issued 1988-12-06
Expired 2005-12-06

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1984-10-05
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
PFIZER LIMITED
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1993-08-20 1 14
Claims 1993-08-20 3 89
Abstract 1993-08-20 1 17
Cover Page 1993-08-20 1 20
Description 1993-08-20 8 246